Evidence map›Paper›PMID 40236773›Full record

ArticleiMeta2025

Enhancement of gut barrier integrity by a

Shiqi Liu, Peiran Cai, Wenjing You, Mingshun Yang, Yuang Tu, Yanbing Zhou, Teresa G Valencak, Yingping Xiao, Yizhen Wang, Tizhong Shan

Abstract read
In one paragraph

Article in iMeta, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. DietaryAntibiotics (Basel, Switzerland) · 2026
    Article
  12. Review
  13. Lemongrass (Animal nutrition (Zhongguo xu mu shou yi xue hui) · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Review
  18. Molecular Mechanisms of Probiotic Action Against Gastrointestinal Cancers.International journal of molecular sciences · 2025
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Shiqi LiuCollege of Animal Sciences Zhejiang University Hangzhou China.ORCID 0000-0001-6395-8273
Peiran CaiCollege of Animal Sciences Zhejiang University Hangzhou China.
Wenjing YouCollege of Animal Sciences Zhejiang University Hangzhou China.
Mingshun YangCollege of Animal Sciences Zhejiang University Hangzhou China.
Yuang TuCollege of Animal Sciences Zhejiang University Hangzhou China.
Yanbing ZhouCollege of Animal Sciences Zhejiang University Hangzhou China.
Teresa G ValencakAustrian Agency for Health and Food Safety Vienna Austria.ORCID 0000-0002-7222-2265
Yingping XiaoState Key Laboratory for Managing Biotic and Chemical Threats to the Quality and Safety of Agro-products, Institute of Agro-product Safety and Nutrition Zhejiang Academy of Agricultural Sciences Hangzhou China.ORCID 0000-0002-7949-1126
Yizhen WangCollege of Animal Sciences Zhejiang University Hangzhou China.
Tizhong ShanCollege of Animal Sciences Zhejiang University Hangzhou China.ORCID 0000-0002-4738-414X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inflammatory bowel disease (IBD) represents a significant challenge to global health, characterized by intestinal inflammation, impaired barrier function, and dysbiosis, with limited therapeutic options. In this study, we isolated a novel strain of

Indexed as

2‐hydroxy‐4‐methylpentanoic acidGADD45Aintestinal barriermetabolitesprobioticsWnt/β‐catenin signaling

Identifiers

PMID40236773
PMCPMC11995189

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.